INI1/SMARCB1 Rpt1 domain mimics TAR RNA in binding to integrase to facilitate HIV-1 replication

Nat Commun. 2021 May 12;12(1):2743. doi: 10.1038/s41467-021-22733-9.

Abstract

INI1/SMARCB1 binds to HIV-1 integrase (IN) through its Rpt1 domain and exhibits multifaceted role in HIV-1 replication. Determining the NMR structure of INI1-Rpt1 and modeling its interaction with the IN-C-terminal domain (IN-CTD) reveal that INI1-Rpt1/IN-CTD interface residues overlap with those required for IN/RNA interaction. Mutational analyses validate our model and indicate that the same IN residues are involved in both INI1 and RNA binding. INI1-Rpt1 and TAR RNA compete with each other for IN binding with similar IC50 values. INI1-interaction-defective IN mutant viruses are impaired for incorporation of INI1 into virions and for particle morphogenesis. Computational modeling of IN-CTD/TAR complex indicates that the TAR interface phosphates overlap with negatively charged surface residues of INI1-Rpt1 in three-dimensional space, suggesting that INI1-Rpt1 domain structurally mimics TAR. This possible mimicry between INI1-Rpt1 and TAR explains the mechanism by which INI1/SMARCB1 influences HIV-1 late events and suggests additional strategies to inhibit HIV-1 replication.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Genome, Viral
  • HIV Integrase / chemistry
  • HIV Integrase / genetics
  • HIV Integrase / metabolism*
  • HIV-1 / physiology*
  • Host-Pathogen Interactions
  • Humans
  • Magnetic Resonance Spectroscopy
  • Models, Molecular
  • Molecular Docking Simulation
  • Protein Binding
  • Protein Domains
  • RNA, Viral / chemistry
  • RNA, Viral / metabolism*
  • SMARCB1 Protein / chemistry
  • SMARCB1 Protein / genetics
  • SMARCB1 Protein / metabolism*
  • Virion / growth & development
  • Virion / metabolism
  • Virus Replication*

Substances

  • RNA, Viral
  • SMARCB1 Protein
  • SMARCB1 protein, human
  • HIV Integrase
  • p31 integrase protein, Human immunodeficiency virus 1